Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-06-25

Clinical Trial Update: Felodipine Event Reduction Study [NA]

View source ↗

Summary

This update notes the completion of a clinical trial evaluating felodipine for event reduction in patients with hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Felodipine (felodipine)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Hypertension | NA | Status: COMPLETED